GALT ▲ +3.5% - Galectin Therapeutics Inc.
$GALT - Galectin Therapeutics Presents New Analyses on Noninvasive Prediction of Variceal Development from its Belapectin Development Program at AASLD Liver Meeting 2026
05-NOV-2026 08:00 AM ET
Share this post
More filings for $GALT
GALT ▲ +1.1% - Galectin Therapeutics Inc.Oct 6, 2026GALT ▲ +0.7% - Galectin Therapeutics Inc.Sep 10, 2026GALT SEC Filing Update (04-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 4, 2026
View full $GALT filing history →💬 Comments
Loading comments…
Leave a comment